

Economy Sep 04

The FTC has been investigating YouTube for the way it handles the data of kids under 13. Young children are protected by a federal law that requires parental consent before companies can collect and share their personal information.
By Rachel Lerman, Marcy Gordon, Associated Press
Nation Jul 13

U.S. health authorities are alerting consumers to a new scam involving fake government warning letters sent to people who tried to buy medicines online or over the phone.
By Matthew Perrone, Associated Press
Making Sen$e Apr 05

Social media giant Facebook says it now believes that up to 87 million people had their data improperly shared with Cambridge Analytica, the political consulting firm that worked for the Trump campaign, and that public profiles for most of the…
By PBS NewsHour
Nation Feb 07

Smart device company will pay $2.2 million in a settlement that for the first time classifies individual television viewing as "sensitive information."…
By Dayana Morales Gomez
Aug 23

By Ed Silverman, STAT
Mylan has raised the list price of EpiPens more than 450 percent since 2004, after adjusting for inflation, according to Elsevier’s Gold Standard Drug Database. A pack of two EpiPens cost about $100 in today’s dollars in 2004, but the…
Jan 27

By Jennifer C. Kerr, Associated Press
WASHINGTON — Another large for-profit college is under government scrutiny — this time, it's DeVry University.
Jun 11

By Anne Flaherty, Associated Press
WASHINGTON — Federal regulators are going after people who raise money online through crowdfunding sites like Kickstarter and GoFundMe but don't follow through on their promises.
Jun 05

By PBS NewsHour
The Federal Trade Commission's recent $1.2 billion settlement over the drug Provigil has brought so-called "pay for delay" deals for generic drugs back into the spotlight. Opponents say these deals delay generic medications to market, costing consumers billions. But drug…
May 28

By Megan Thompson
The Federal Trade Commission announced today it has settled a lawsuit against drug company Cephalon, now owned by Teva Pharmaceutical Industries, for $1.2 billion – the largest settlement of its kind to date.
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.